NasdaqGS:MEDPLife Sciences
Is It Time To Reassess Medpace Holdings (MEDP) After The Recent Share Price Pullback
If you are wondering whether Medpace Holdings at around US$442 per share still offers value, you are not alone, especially after its strong multi year share price performance.
The stock is up 3.3% over the last week, even after a 24.8% decline over the past month and a 22.6% decline year to date, set against a 29.7% return over 1 year and 128.1% and 167.7% returns over 3 and 5 years respectively.
Recent coverage of Medpace has focused on its role as a contract research organization in...